Dermatological manifestations in cardiofaciocutaneous syndrome: a prospective multicentric study of 45 mutation‐positive patients
- 23 August 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 180 (1) , 172-180
Abstract
Background Data on dermatological manifestations of cardiofaciocutaneous syndrome (CFCS) remain heterogeneous and almost without expert dermatological classification. Objectives To describe the dermatological manifestations of CFCS; to compare them with the literature findings; to assess those discriminating CFCS from other RASopathies, including Noonan syndrome (NS) and Costello syndrome (CS); and to test for dermatological phenotype–genotype correlations. Methods We performed a 4‐year, large, prospective, multicentric, collaborative dermatological and genetic study. Results Forty‐five patients were enrolled. Hair abnormalities were ubiquitous, including scarcity or absence of eyebrows and wavy or curly hair in 73% and 69% of patients, respectively. Keratosis pilaris (KP), ulerythema ophryogenes (UO), palmoplantar hyperkeratosis (PPHK) and multiple melanocytic naevi (MMN; over 50 naevi) were noted in 82%, 44%, 27% and 29% of patients, respectively. Scarcity or absence of eyebrows, association of UO and PPHK, diffuse KP and MMN best differentiated CFCS from NS and CS. Oral acitretin may be highly beneficial for therapeutic management of PPHK, whereas treatment of UO by topical sirolimus 1% failed. No significant dermatological phenotype–genotype correlation was determined. Conclusions A thorough knowledge of CFCS skin manifestations would help in making a positive diagnosis and differentiating CFCS from CS and NS.Keywords
This publication has 54 references indexed in Scilit:
- Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in developmentBritish Journal of Dermatology, 2011
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensationTrends in Biochemical Sciences, 2011
- SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlationsHuman Mutation, 2011
- Cardio‐facio‐cutaneous syndrome: Does genotype predict phenotype?American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011
- Noonan syndrome and clinically related disordersBest Practice & Research Clinical Endocrinology & Metabolism, 2011
- The face of Noonan syndrome: Does phenotype predict genotypeAmerican Journal of Medical Genetics Part A, 2010
- RASopathies: Clinical Diagnosis in the First Year of LifeMolecular Syndromology, 2010
- Spectrum of MEK1 and MEK2 gene mutations in cardio-facio-cutaneous syndrome and genotype–phenotype correlationsEuropean Journal of Human Genetics, 2009
- Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype phenotype relationships and overlap with Costello syndromeJournal of Medical Genetics, 2007
- The cardiofaciocutaneous syndromeJournal of Medical Genetics, 2006